Chronic Kidney Disease Clinical Trials Recruiting in the US
160 studies for Chronic Kidney Disease are recruiting at 934 US sites, according to ClinicalTrials.gov data processed .
Chronic kidney disease is a long-term condition in which the kidneys gradually lose their ability to filter waste and fluid from the blood.
Recruiting now
Top Chronic Kidney Disease studies by number of US sites
Showing 30 studies, most US recruiting sites first.
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
NCT05485961
- Phase 2/3
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 149 US recruiting sites
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
NCT06742723
- Phase 3
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 116 US recruiting sites
- Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
NCT07271186
- Phase 2
- Ages 18 to 80 years
- Sex: All
- Recruiting sites
- 56 US recruiting sites
- A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
NCT07268638
- Phase 2
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 29 US recruiting sites
- A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
NCT07783802
- Phase 2
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 29 US recruiting sites
- SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
NCT06001827
- Interventional
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 28 US recruiting sites
- A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
NCT06712654
- Phase 2
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 24 US recruiting sites
- A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
NCT07355062
- Phase 3
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 24 US recruiting sites
- A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
NCT04671771
- Interventional
- Ages 18 to 90 years
- Sex: All
- Recruiting sites
- 21 US recruiting sites
- Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
NCT06190717
- Interventional
- Ages 18 to 84 years
- Sex: All
- Recruiting sites
- 20 US recruiting sites
- A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
NCT06933472
- Phase 3
- Ages 12 years and older
- Sex: All
- Recruiting sites
- 19 US recruiting sites
- Recruiting sites
- 16 US recruiting sites
- Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
NCT04634916
- Interventional
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 14 US recruiting sites
- Recruiting sites
- 14 US recruiting sites
- Recruiting sites
- 13 US recruiting sites
- Recruiting sites
- 13 US recruiting sites
- Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
NCT06217302
- Phase 3
- Ages 18 to 75 years
- Sex: All
- Recruiting sites
- 13 US recruiting sites
- Recruiting sites
- 13 US recruiting sites
- CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
NCT05931276
- Phase 3
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 12 US recruiting sites
- Recruiting sites
- 12 US recruiting sites
- Recruiting sites
- 10 US recruiting sites
- A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
NCT07624305
- Phase 3
- Ages 18 to 99 years
- Sex: All
- Recruiting sites
- 10 US recruiting sites
- Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
NCT06858319
- Phase 3
- Ages 18 to 100 years
- Sex: All
- Recruiting sites
- 9 US recruiting sites
- An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
NCT05106387
- Observational
- Ages 18 to 70 years
- Sex: All
- Recruiting sites
- 8 US recruiting sites
- Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
NCT05465044
- Interventional
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 8 US recruiting sites
- Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
NCT06360380
- Interventional
- Ages 21 to 79 years
- Sex: All
- Recruiting sites
- 8 US recruiting sites
- Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
NCT06516653
- Interventional
- Ages 18 to 80 years
- Sex: All
- Recruiting sites
- 8 US recruiting sites
- PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
NCT06422871
- Observational
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 7 US recruiting sites
- Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
NCT06906627
- Interventional
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 7 US recruiting sites
- Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
NCT06906640
- Interventional
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 7 US recruiting sites
FAQ
Common questions
What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Chronic Kidney Disease clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.